First-line HLX07 vs placebo combined with serplulimab and chemotherapy for nasopharyngeal carcinoma: A randomized, double-blind, multicenter phase 2 study.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Wenfeng Fang, Xiaohong Ai, Feng Lei, Dong Ma, Hongyan Ni, Xiaoli Hou, Yan Wang, Qingyu Wang, Li Zhang
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162532795
Cites:
Cited by:
Related to: